Akoya Biosciences completes merger with Quanterix; shareholders receive 0.1461 QTRX shares + $0.38 cash per share

Akoya Biosciences, Inc.

Merger closed July 8, 2025; Akoya is now a wholly owned subsidiary of Quanterix (QTRX).
Per share: 0.1461 Quanterix shares plus $0.38 cash; adjustments ensure no more than 19.99% of QTRX shares or $20M cash issued.
All outstanding Akoya RSUs and options converted or cancelled per merger agreement.
Board and executive officers replaced with Quanterix appointees; Akoya common stock delisted from Nasdaq.
Prior credit agreement, ESPP, and equity distribution agreement terminated in connection with merger.

item 1.02item 2.01item 3.01item 3.03item 5.03item 5.01item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.